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Introduction
Ischemic Heart Disease (IHD) was the leading cause of death worldwide in 2010. 1 Age standardized IHD mortality has declined in high income nations since 1980, due in large part to a combination of improved primary prevention (improvements in risk factors) and improved secondary prevention (improved treatment of acute and chronic IHD). [2] [3] [4] [5] On average, IHD deaths have been pushed to older ages in the high income regions. However, in the past the IHD epidemic has evolved variably in different regions and nations. 6 In some low and middle income regions, accelerated lifestyle changes, economic stresses, and other factors may be leading to increased IHD incidence often occurring in middle-aged adults, and changing the late 20 th century paradigm of IHD as a disease of the affluent and the elderly. 7 Measuring total IHD deaths and age-standardized IHD mortality rates is essential for assessing the burden of IHD and planning prevention programs. Global and regional analysis of IHD mortality trends is complicated by numerous factors, including changes in International Classification of Diseases (ICD) categories over time, sparse or low quality original vital registration data in some regions, and variations in the degree of incorrect coding of IHD deaths.
As part of the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2010 Study, we employed novel estimation methods in order to assess numbers of IHD deaths, IHD mortality rates, and years of life lost (YLL) due to IHD for 21 world regions over the years 1980-2010, and provide uncertainty ranges for these estimates.
Methods

Definition of IHD death
Detailed IHD mortality definitions and estimation methods are available elsewhere. 8, 9 In brief, century paradigm of IHD as a disease of the affluent and the elderly. 7 Measuring total IHD deaths and age-standardized IHD mortality rates is essential for as sse se ess ss ssin in ing g th th the e bu urd rd rde en en of IHD and planning preve e en n nt tio o on programs. G G Globa ba al l l a an and regional analysis of H HD D D mortality y tr tren en nds s i i is co co comp mp mpli li lica cate te ted d d b by y n num m mer r rous s s f fa act tor or ors, s, i i inc nc cl lud ud din n ng g ch ch chan n nge ge es s i in in In In nte tern rn r a a atio io ona na al l Cl Cl las as assi si sifi fi f ca cati ti ion on on o of f f D Di Dise seas ases es e (IC IC CD) D) D) c c cat at ateg egor or orie ie ies s s ov ov ver er e t t tim m me, e, spa pa par rs rse e or or o l low ow wu ua ual li lity ty y o ori ri rigi gi g na na nal l l vi vi ita al l r egistration d dat at ata a a in in n s s som om me e e re e egi gi gion on ons, s, s an an nd d va va vari ri riat at tio io ions ns ns i i in n n th th he e de de degr gr gree ee e o o of f f i inc nc cor or orre re rect ct ct c c cod od din in ing g g of of of I I IHD H deaths. . f f f IHD deaths fall into two categories: acute myocardial infarction (AMI) deaths and sudden cardiac deaths. IHD has been consistently defined as an underlying cause of death across ICD revisions (most recently ICD-10 I20-I25, ICD-9 410-414). 8 A proportion of IHD deaths are erroneously assigned on death certificates to either nonfatal ICD conditions (e.g., "senility") or conditions not defined as an underlying cause of death (for example, heart failure, hypertension, or cardiac conduction disorders). The GBD developed methods for systematically re-allocating these undefined or erroneously assigned deaths to IHD based on the total distribution of actual causes of death by the country, sex, age, and year. 8, 10
IHD mortality source data
Cause specific mortality data were gathered from vital registration, verbal autopsy, surveillance systems, surveys/censuses, or police report and aggregated in a central database. Data sources and availability varied substantially among GBD 2010 regions ( Supplemental Tables 1 and 2) .
Causes of death were mapped across revisions and national variations of the ICD over time, incomplete data were adjusted for reporting bias, erroneously coded deaths were redistributed, deaths were distributed to GBD age categories, and trends were smoothed to eliminate year-toyear fluctuations. 1 No "gold standard" for validating GBD classification and redistribution algorithms exist (such as large scale autopsy studies) so countries with the most complete vital registration and adherence to recommended cause of death coding practices were used as the standard. Even in the best of settings, there are problems with erroneous coding of deaths to inappropriate ICD codes, and GBD methods have been demonstrated to improve cause-of-death estimation. 11 Overall numbers of IHD deaths increased 21.5% after redistribution of undefinedcoded deaths to IHD ( Supplemental Table 3 ). Globally, 76.9% of deaths incorrectly coded as "heart failure", 47.2% incorrectly coded as "hypertension", and 89.9% incorrectly coded as "all C C Cau us uses of deat ath h h we were re m map ap appe pe ped d d ac acro ro os ss ss r rev ev visio o ons s s an nd d n nat ti tio on onal al l v v var ari ia ati i ion ns s of of f t the he e I I ICD CD D ov ve ver r ti im me me, n nco co comp mp mple lete te e d d dat ata a we we ere re a adj dj djus u te e ed d fo fo for r r re re repo po ort t tin in ing g g bi i ias as a , , , er r rro r ne ne neou ou ous s sly y y co co code de ed d d de de eat t ths hs w w wer er e e e re re red d dist st tri ibu bu b te te ed, d, , deaths were di di dist st stri ribu bu bute te ted d d to t G G GBD BD BD a a age ge ge c cat at teg eg egor or orie ie ies, s, s, an an and d d tr tr t en n nds ds ds w w wer er re e e sm sm smoo oo ooth th thed ed ed t t to o el el e im im imin in nat at a e year-to-by guest on April 20, 2017 http://circ.ahajournals.org/ Downloaded from cardiac conduction disorders" were re-distributed to IHD. 9
IHD mortality models
Multilevel IHD mortality regression models were used to improve estimation for regions with sparse or outlying mortality data (Supplemental Material). Models include fixed effects from covariates, and nested random effects on super-region, region, country, and age. Separate models were developed for males and females. Potential model covariates and their directions of effect were selected based on a comprehensive review by the comparative risk assessment arm of the GBD 2010 study, and included standard IHD risk factors (country mean blood pressure and cholesterol), behavioral variables (physical activity, diet, alcohol consumption) and contextual variables (per capita income, mean education level, and health system access). 9 Independent ecological associations of covariates with IHD mortality were first tested in mixed effects regressions, adding covariates stepwise, added in order from higher to lower evidence of causal association with IHD in past studies. 9 Seventeen covariates produced multivariate coefficients with a plausible direction and were significant at the <0.05 level and were retained for subsequent models. Using IHD mortality data and the covariates selected, the Cause of Death Mean body mass index, systolic blood pressure (mm Hg), total cholesterol (mmol/l), and level of tobacco smoking (active smoking prevalence and mean cigarettes/day) were all significant predictors of IHD mortality and contributed most frequently to individual IHD models developed for both men and women. 9 Alcohol (liters per capita) was the only covariate entered into models without specifying direction of association (i.e., not specifying benefit or harm) and contributed to 11% of male models and 42% of female models. Table 4 ).
Crude IHD mortality rates were calculated by dividing annual IHD deaths by the total population (all ages) at risk in that year. These rates were also age standardized by the direct method, using ike lower educational status (years per capita), lower income (U.S. dollars per ca ca api pi ita ta t ) ), ), h h hig ig igh h h elevation (percent of population dwelling at >1,500 meters) and high war deaths (rate per 1,000 pe ers rs son on on-y -yea ea ears rs r ) ) ) al ll l l c co cont n ributed more to female tha a an n n m m male ensemble e mo m m de de els ls ls. . 9 Table 4 ).
Results
There were over 7.0 million IHD deaths worldwide in 2010, compared with 4.5 million in 1980, 5.2 million in 1990, and 6.3 million in 2000 (Supplemental Table 5 ). In 2010, the highest age- (Figure 4) .
Eastern Europe/Central Asia experienced steep increases in the age standardized IHD death rate after 1990 (around the time of the break-up of the Soviet Union); age standardized rates there declined starting in the mid-2000's (Figure 3) .
Among the high-income regions, age standardized IHD mortality rates decreased most in Australasia (approximately 51% decrease from 1990 to 2010), Western Europe (46% decrease),
and North America (43% decrease, Table 1 ). The lowest age standardized IHD mortality rates over the period 1980-2010 were observed in the sub-Saharan Africa, Andean Latin America, and
Asia-Pacific regions.
Regional totals of YLL due to IHD were highest in regions with larger populations, high IHD mortality rates, and younger average age at IHD death. The highest YLL in all years was observed in South Asia (a 72% increase since 1990), followed by Eastern Europe ( 1 1 1) . ). ). T T The he e l l low ow owes es st t t ag ag age e e st st stan an a da da dard rd diz iz zed ed ed I I IHD HD D m m mor or orta ta t lity rates rates and older average age at IHD death, the most remarkable decreases in YLL from 1990 to 2010 occurred in the high income regions of Australasia (34% decrease) and Western Europe (32% decrease).
Discussion
In the overall GBD Study, IHD was the leading cause of death worldwide in 2010. 1 Our analysis of IHD mortality trends found that global age standardized IHD mortality has declined since 1980. At the regional level, another, more complex story emerged: the age standardized IHD death rate declined steeply since 1980 in the Western, high income regions but increased in 15 There is strong evidence that heavy alcohol exposure is the cause of many deaths ascribed to IHD in this region, though the causal pathway needs to be better defined. 15, 16 Perhaps most concerning are high age-standardized IHD death rates in regions like North Dietary patterns have shifted worldwide in both high and low income regions to more consumption of edible oils, animal fats, and sugar sweetened beverages. 18 Earlier adoption of unhealthy lifestyles and higher risk factor exposures at younger ages may, in part, explain the increasing incidence of IHD at younger ages in regions like South Asia. 19, 20 East Asia (comprised mostly of China) was another region with IHD mortality increase in our analysis: in an earlier GBD Study analysis of cholesterol trends, was among the few regions that experienced an increase in mean cholesterol since 1980. 21 However, not all IHD epidemics are the same:
there are past examples of IHD mortality declines in the face of adverse cholesterol or tobacco trends. 22 Our analysis shows that at a global level, traditional risk factors like tobacco smoke, high cholesterol, and high blood pressure play a central role in explaining regional differences in IHD mortality rates. Because no causal direction was specified and patterns of alcohol use were not distinguished (i.e., binge or heavy compared with moderate alcohol consumption), our analysis did not accurately characterize the association of alcohol consumption with IHD.
Regional air pollution level was not a significant covariate in the IHD mortality models, but epidemiologic research has established air pollution as a risk factor for IHD, 23 and its contribution will be explored in subsequent GBD analyses.
The association of lower regional economic and educational status with higher IHD rates ncreasing incidence of IHD at younger ages in regions like South Asia. 19, 20 Ea ast st t A A Asi ia a a comprised mostly of China) was another region with IHD mortality increase in our analysis: in an n e e ear ar arli li lier er G G GBD B B S S Stu tu tudy d analysis of cholesterol tren en nds ds, was among th th he fe few w w r regions that experienced an n i i inc n rease in n m mea ea ean ch ch chol ol les es ste te tero ro rol l si sinc nc nce e 19 1980. 2 Along with the public health community's emphasis on prevention, the impact of improved access to acute cardiac care should not be forgotten. Aspirin and a beta-blocker for all acute myocardial infarctions and revascularization using low-cost thrombolytic for ST-elevation myocardial infarctions are often life-saving and may be affordable in low resource settings. 26 The strengths of this analysis of global trends in IHD mortality were collection of a comprehensive set of national mortality data from a variety of sources, adjustments for biases introduced by ICD version changes and for death registration coding practices, and methods for accounting for and describing covariate parameter and statistical model selection uncertainty.
Limitations of the analysis include incomplete data for many regions, especially sub-Saharan Africa, and the ecological nature of the associations found between covariates and IHD mortality. Unexpectedly, diabetes contributed more to male models than to female models, findings that may be explained by inclusion of non-traditional IHD predictor covariates in the models that absorbed some of these covariates' effects, or differential competing risk with other causes of death in males compared with females. Here we summarize ensemble modeling and CODEm methods; interested readers can access more detailed information about the CODEm method and ensemble modeling elsewhere. 1 In brief, ensemble models combine predictions of multiple individual models. Ensemble models estimated in a variety of fields have demonstrated smaller prediction error than the best individual model. Another advantage of ensemble models is that they capture not only input parameter uncertainty, but also uncertainty stemming from model specification. In order to combine predictions from multiple models (varying in model form, outcome definition, and covariate selection), individual model results are usually weighted before averaging to produce ensemble estimates.
CODEm worked with two main model forms: linear mixed effects models and spatial-temporal models.
Linear mixed effects models assumed fixed effects of covariates, and hierarchical random effects by superregion, region, country, and age. Spatial-temporal models begin with the mixed effects models, but remove the random country effect, instead calculating residuals (predicted -observed estimate) and
performing local regressions on nearby data (in the dimensions of country ("space") and time (year).
Gaussian Process Regression was used to carry forward sampling and non-sampling variance in the source data. Two types of dependent cause of death variables were used: mortality rates and "cause fraction" (e.g., proportion of IHD mortality in all-cardiovascular disease mortality or all-cause mortality). The two model forms (mixed effects linear models and spatial-temporal models) and two outcome definitions (rate and cause fraction) led to four model "families" (four combinations of form and outcome) contributing to ensemble models.
Covariates were added stepwise to models, in order of a prior literature-based assumptions about causal association and strength of association, and kept in models if the covariate showed estimated direction of association and if the multivariate covariate coefficient was significant at the <0.05 level.
Biological/physiological covariates (e.g., country mean blood pressure or cholesterol), behavioral covariates (country mean dietary consumption and physical activity level) and contextual covariates (e.g., mean education level, per capita income, and health system access) were examined. 2 
